Lupin launches Azilsartan Medoxomil tablets in the United States
Company receives US FDA approval and secures 180-day generic drug exclusivity for hypertension treatment
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
We’re building for global markets, not just domestic scale
As the next-generation leader of the company, Nupur Shah, CEO of Cyano Pharma is steering the 60-year-old pharmaceutical company…
USFDA and EUDRA dashboards offer lessons for strengthening India’s regulatory transparency
Milind Sathe analyses how public regulatory dashboards can support pharmaceutical innovation, compliance and patient safety in…
From fintech to aesthetic injectables: Lessons in navigating regulatory formalisation
Rishi Agrawal, CEO, TeamLease RegTech cautions that the recent CDSCO clarification on injectable cosmetic products signals a…
Karnataka holds 64th Vision Group on Biotechnology meeting to review biotech ecosystem
Meeting discusses biotechnology strategy, AI integration, biomanufacturing and financing ecosystem
Glenmark launches Methylene Blue Injection USP in US
Generic injectable approved as bioequivalent to ProvayBlue Injection 50 mg/10 mL
ILAMED expands international presence with centres in Kenya, Ethiopia and Thailand
Institute to launch Cairo centre in September 2026 as part of its overseas expansion
Novartis India launches Pluvicto for PSMA-positive metastatic prostate cancer
Radioligand therapy approved for eligible patients with PSMA-positive prostate cancer in India
Alembic receives USFDA final approval for Tretinoin Cream USP, 0.05%
ANDA approved for Tretinoin Cream USP, 0.05%, referencing Retin-A Cream, 0.05%
Ipca Laboratories and Bhami’s Research Laboratory signs global licensing agreement for subcutaneous…
Agreement enables development and commercialisation of monoclonal antibody products for oncology and inflammatory diseases using…
CDSCO’s cosmetic regulations: The rules exist. The enforcement does not
People have died in India’s aesthetic clinics. Not in rare surgical catastrophes, but in routine cosmetic procedures performed by…
Why ingredient transparency matters more than ever in cosmeceuticals
Dr Aisshwarya Panddit highlights why ingredient transparency has become essential in modern cosmeceuticals amid rising consumer…
Indore Pharma Summit: Mapping the future of India pharma
From AI and smart manufacturing to sustainability,quality culture,faster drug development,and CDMO opportunities,the summit…
Parexel to present at eight sessions during DIA Global Annual Meeting 2026
Company representatives to participate in discussions on AI, clinical trials, real-world evidence, quality management and…
Axplora consolidates UDCA manufacturing at Vizag site
Company to transition ursodeoxycholic acid production from Italy to India by end-2026 as part of integrated manufacturing…
Alembic receives USFDA tentative approval for Larotrectinib Capsules ANDA
Company becomes sole first applicant for generic Larotrectinib Capsules with Paragraph IV certification
ASSOCHAM projects India pharma market at USD 120–130 billion by 2030
Knowledge paper outlines growth drivers, biosimilars opportunity and priorities for India Pharma 2030
Glenmark launches Winlevi for acne vulgaris across European markets
Launch follows European Commission authorisation and expands availability of clascoterone cream for adults and adolescents in…
CDSCO approves Trastuzumab Deruxtecan for first-line HER2-positive breast cancer
Approval expands indication for Trastuzumab Deruxtecan in combination with Pertuzumab for adults with unresectable or metastatic…
Merck India and Oval Fertility sign MoU to expand access to fertility care
Partnership focuses on clinical capability building, patient support, technology integration and data-led approaches to improve…